Ventricular electrical remodeling in compensated cardiac hypertrophy

Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention

Volumn , Issue , 2008, Pages 305-315

  Winckels, Stephan K G ^a   Vos, Marc A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955438604     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-854-8_20     Document Type: Chapter

References (71)

1. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56(1):56-64.
2. Ahmad F, Siedman J, Seidman C. The genetic base for cardiac remodeling. Annu Rev Genomics Hum Genet 2005;6:185-216.
3. Stevenson WG, Stevenson LW. Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001;12(1):112-114.
4. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347(18):1397-1402.
5. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000;140(6):848-856.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322(22):1561-1566.
7. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999;42(2):270-283.
8. Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 2004;62(2):426-436.
9. Sipido K, Volders P, De Groot S, et al. Enhanced Ca (2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: Potential link between contractile adaptation and arrhythmogenesis. Circulation 2000;102(17):2137-2144.
10. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98(21):2334-2351.
11. Hill JA. Electrical remodeling in cardiac hypertrophy. Trends Cardiovasc Med 2003;13(8):316-322.
12. Richard S, Leclercq F, Lemaire S, Piot C, Nargeot J. Ca2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res 1998;37(2):300-311.
13. Dobrev D. Electrical remodeling in atrial fibrillation. Herz 2006;31(2):108-112.
14. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004;62(2):368-377.
15. Hasenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 1998;39(1):60-76.
16. Kleiman RB, Houser SR. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 1989;256(5 Pt. 2):H1450-H1461.
17. Rials SJ, Wu Y, Ford N, et al. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995;91(2):426-430.
18. Verduyn S, Vos M, Van Der Zande J, Van Der Hulst F, Wellens H. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 1997;34(3):453-463.
19. Gussak I, Chaitman BR, Kopecky SL, Nerbonne JM. Rapid ventricular repolarization in rodents: Electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol 2000;33(2):159-170.
20. Kleiman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol 1988;255(6 Pt. 2):H1434-H1442.
21. Charpentier F, Baudet S, Le Marec H. Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. Pacing Clin Electrophysiol 1991;14(11 Pt. 2):1735-1741.
22. Rials SJ, Wu Y, Xu X, Filart RA, Marinchak RA, Kowey PR. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997;96(4):1330-1336.
23. Naqvi RU, Tweedie D, MacLeod KT. Evidence for the action potential mediating the changes to contraction observed in cardiac hypertrophy in the rabbit. Int J Cardiol 2001;77(2-3):189-206.
24. Furukawa T, Myerburg RJ, Furukawa N, Kimura S, Bassett AL. Metabolic inhibition of ICa, L and IK differs in feline left ventricular hypertrophy. Am J Physiol 1994;266(3 Pt. 2):H1121-H1131.
25. De Groot S, Schoenmakers M, Molenschot M, Leunissen J, Wellens H, Vos M. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarizationdependent ventricular arrhythmias. Circulation 2000;102(17):2145-2151.
26. Thomsen MB, Volders PG, Beekman JD, Matz J, Vos MA. Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol 2006;48(6):1268-1276.
27. Tsuji Y, Opthof T, Yasui K, et al. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation 2002;106(15):2012-2018.
28. Tsuji Y, Zicha S, Qi X, Kodama I, Nattel S. Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: Discrete arrhythmogenic consequences related to differential delayed-rectifier changes. Circulation 2006;113(3):345-355.
29. Chugh SS, Johnson SB, Packer DL. Altered response to ibutilide in a heart failure model. Cardiovasc Res 2001;49(1):94-102.
30. Zicha S, Maltsev VA, Nattel S, Sabbah HN, Undrovinas AI. Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure. J Mol Cell Cardiol 2004;37(1):91-100.
31. Davey PP, Barlow C, Hart G. Prolongation of the QT interval in heart failure occurs at low but not at high heart rates. Clin Sci (Lond) 2000;98(5):603-610.
32. Schoenmakers M, Ramakers C, Van Opstal J, Leunissen J, Londono C, Vos M. Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog. Cardiovasc Res 2003;59(2):351-359.
33. Tsuji Y, Opthof T, Kamiya K, et al. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res 2000;48(2):300-309.
34. Vos M, De Groot S, Verduyn S, et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998;98(11):1125-1135.
35. Volders P, Sipido K, Vos M, et al. Downregulation of delayed rectifier K (+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999;100(24):2455-2461.
36. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73(2):379-385.
37. Kääb S, Nuss HB, Chiamvimonvat N, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacinginduced heart failure. Circ Res 1996;78(2):262-273.
38. Kaab S, Dixon J, Duc J, et al. Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998;98(14):1383-1393.
39. Rozanski GJ, Xu Z, Whitney RT, Murakami H, Zucker IH. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol 1997;29(2):721-732.
40. Gillis AM, Geonzon RA, Mathison HJ, Kulisz E, Lester WM, Duff HJ. The effects of barium, dofetilide and 4-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J Pharmacol Exp Ther 1998;285(1):262-270.
41. McIntosh MA, Cobbe SM, Kane KA, Rankin AC. Action potential prolongation and potassium currents in left-ventricular myocytes isolated from hypertrophied rabbit hearts. J Mol Cell Cardiol 1998;30(1):43-53.
42. Rials SJ, Xu X, Wu Y, Marinchak RA, Kowey PR. Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am J Physiol 1998;275(4 Pt. 2):H1216-H1224.
43. Ten Eick RE, Zhang K, Harvey RD, Bassett AL. Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc Drugs Ther 1993;7(Suppl. 3):611-619.
44. Song LS, Pi Y, Kim SJ, et al. Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy. Circ Res 2005;97(5):457-464.
45. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitationcontraction coupling in canine tachycardia-induced heart failure, I: Experimental studies. Circ Res 1999;84(5):562-570.
46. Antoons G, Stengl M, Ramakers C, Sipido K, Vos M. Properties of sodium currents in the dog with chronic atrioventricular block (abstract). J Mol Cell Cardiol 2005;39(1):195.
47. Valdivia CR, Chu WW, Pu J, et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005;38(3):475-483.
48. Ramakers C, Vos M, Doevendans P, et al. Coordinated down-regulation of KCNQ1 and KCNE1 expression contributes to reduction of I (Ks) in canine hypertrophied hearts. Cardiovasc Res 2003;57(2):486-496.
49. Stengl M, Ramakers C, Donker D, et al. Temporal patterns of electrical remodeling in canine ventricular hypertrophy: Focus on I (Ks) downregulation and blunted beta-adrenergic activation. Cardiovasc Res 2006;72(1):90-100.
50. Borlak J, Thum T. Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J 2003;17(12):1592-1608.
51. Akar FG, Wu RC, Juang GJ, et al. Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure. Am J Physiol Heart Circ Physiol 2005;288(6):H2887-H2896.
52. Rose J, Armoundas AA, Tian Y, et al. Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol 2005;288(5):H2077-H2087.
53. Zicha S, Xiao L, Stafford S, et al. Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts. J Physiol 2004;561(Pt. 3):735-748.
54. Huang B, Qin D, El-Sherif N. Early down-regulation of K+ channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol 2000;11(11):1252-1261.
55. Hill JA, Karimi M, Kutschke W, et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000;101(24):2863-2869.
56. Peschar M, Vernooy K, Vanagt W, Reneman R, Vos M, Prinzen F. Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res 2003;58(3):510-517.
57. Schreiner K, Kelemen K, Zehelein J, et al. Biventricular hypertrophy in dogs with chronic AV block: Effects of cyclosporin A on morphology and electrophysiology. Am J Physiol Heart Circ Physiol 2004;287(6):H2891-H2898.
58. Xydas S, Rosen RS, Ng C, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 2006;25(1):7-15.
59. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 2004;109(19):2263-2265.
60. Kassiri Z, Zobel C, Nguyen TT, Molkentin JD, Backx PH. Reduction of I (to) causes hypertrophy in neonatal rat ventricular myocytes. Circ Res 2002;90(5):578-585.
61. Lebeche D, Kaprielian R, Del Monte F, et al. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 2004;110(22):3435-3443.
62. Zobel C, Kassiri Z, Nguyen TT, Meng Y, Backx PH. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Circulation 2002;106(18):2385-2391.
63. Hsieh MH, Chen YJ, Lee SH, Ding YA, Chang MS, Chen SA. Proarrhythmic effects of ibutilide in a canine model of pacing induced cardiomyopathy. Pacing Clin Electrophysiol 2000;23(2):149-156.
64. Pye MP, Cobbe SM. Arrhythmogenesis in experimental models of heart failure: The role of increased load. Cardiovasc Res 1996;32(2):248-257.
65. Bailly P, Benitah JP, Mouchoniere M, Vassort G, Lorente P. Regional alteration of the transient outward current in human left ventricular septum during compensated hypertrophy. Circulation 1997;96(4):1266-1274.
66. Volders P, Sipido K, Vos M, Kulcsar A, Verduyn S, Wellens H. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation 1998;98(11):1136-1147.
67. Kurita T, Ohe T, Marui N, et al. Bradycardiainduced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 1992;69(6):628-633.
68. Harding JD, Piacentino V 3rd, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001;104(11):1241-1247.
69. Katz AM. Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management. Philadelphia: Lippincott Williams & Wilkins, 2000.
70. Volders P. Cellular mechanisms of acquired torsades de pointes in the hypertrophied canine heart; the substrate and the trigger. Thesis. Maastricht, the Netherlands, 1999.
71. Donker D, Volders P, Arts T, et al. End-diastolic myofiber stress and ejection strain increase with ventricular volume overload-Serial in-vivo analyses in dogs with complete atrioventricular block. Basic Res Cardiol 2005;100(4):372-382.